3,5-bis(2H5)ethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

• ChemBase编号: 172154
• 分子式: C26H33NO6
• 平均质量: 455.54332
• 单一同位素质量: 455.23078778
• SMILES: N1C(=C(C(C(=C1C)C(=O)OCC)c1ccccc1/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C
• Canonical SMILES: CCOC(=O)C1=C(C)NC(=C(C1c1ccccc1/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C
• InChI: InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+
• InChIKey: GKQPCPXONLDCMU-CCEZHUSRSA-N

名称和登记号

名称

• IUPAC标准名: 3,5-bis(^2H₅)ethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
• IUPAC传统名: 3,5-bis(^2H₅)ethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
• 别名: (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester-d10; GR-43659X-d10; GX-1048-d10; Caldine-d10; Lacipil-d10; Lacirex-d10; Motens-d10; Lacidipine-d10

登记号

• PubChem SID: 164228064
• PubChem CID: 45039638

理论计算性质

• 质子受体: 4
• 质子供体: 1
• LogD (pH = 5.5): 3.9171872
• LogD (pH = 7.4): 4.1805105
• Log P: 4.1851535
• 摩尔折射率: 129.9138 cm^3
• 极化性: 49.212093 Å^3
• 极化表面积: 90.93 Å^2
• 可自由旋转的化学键: 11
• 里宾斯基五规则: true

分子性质

理化性质

• 溶解度: Chloroform; Ethyl Acetate
• 外观: White Solid
• 熔点: 174-175°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - L098002

A dihydropyridine calcium channel blocker. Antihypertensive.

参考文献

• Safar, M., et al.: Clin. Pharmacol. Ther., 46, 94 (1989)
• Kharat, V.R., et al.: J. Pharm. Biomed. Anal., 28, 789 (1989)
• McCormack, A.J., et al.: Drugs, 63, 2327 (1989)